Still think of TB, typhoid and gonorrhea as infections from the past? WHO's terrifying report will make you think again.
Tuberculosis
TB ought to be treatable within six months once people are prescribed a course of drugs including the once potent antibiotics isoniazid and rifampicin. But today, resistance has emerged not only to these medicines, but to the wider range of pharmaceuticals used to treat the disease. This has led to the emergence of multi-drug-resistant TB, the still less treatable extensively drug-resistant TB (XDR-TB), and even to total drug-resistant TB, which has only officially been confirmed in India. Countries such as South Africa have run out of treatment options for many of their patients and are having to discharge them from hospital. Resistance to TB has reached a global scale with XDR-TB now reported in 92 countries.Gonorrhea
The sexually transmitted nature of this infection makes it something many are reluctant to talk about or admit to having. However, it's long been thought of as easily treatable and nothing much to fear. Once fixable with penicillin and tetracycline, the bacteria behind the disease have developed such high levels of resistance that there is only one drug left that can treat it. Even this antibiotic, ceftriaxone, is becoming less effective. With last-resort drugs losing their impact, this sexually transmitted infection (STI) could spread throughout the population.Klebsiella
It's likely that you've never heard of this common bacterium, which can cause a wide range of conditions including pneumonia, urinary tract infections, septicaemia, meningitis and diarrhoea. It fits into a wider group of bacteria with the apt acronym of Eskape owing to their ability to avoid the effects of the antibiotics used against them. The acronym stands for the names of the bacterial group members: Enterococcus faecium; Staphylococcus aureus; Klebsiella pneumoniae; Acinetobacter baumannii; Pseudomonas aeruginosa; and Enterobacter. Klebsiella and the rest of this group are increasingly being acquired in hospitals. While we fear MRSA, it is in fact a declining threat in hospitals; at the same time Eskape pathogens are causing more and more problems. As the WHO report highlighted, routine hospital visits or treatments could result in these previously treatable bacteria having fatal consequences.Typhoid
Routine
vaccination against typhoid means it's not a disease that is often on
our radar, and when it is it's rarely something we fear. However, the
disease still affects 21.5 million people each year in the developing
world, and globalisation means travel to potential sources of infection
is more common. As a result, more than 5,000 people in the US are
infected annually after eating contaminated food and drink. Typhoid
fever, which is caused by the bacterium salmonella typhi, is treated
with antibiotics, but resistance to multiple antibiotics is increasing.
Reduced susceptibility to the fluoroquinolone class of drugs and the
emergence of multi-drug-resistance has complicated the treatment of
infections, especially those acquired in south Asia. Since a vaccination
exists, the key is to receive this before you get on to a plane.
Otherwise, consuming that innocent-looking vegetable on a trip to
Thailand could leave you with a potentially fatal fever topping 100F.
Although
resistance to these diseases is yet to emerge, public awareness of them
has reduced as a result of effective treatments. But in an era of
resistance there is always the potential for them to return as a serious
public health threat. Although rates of syphilis are low, they have
been increasing in the UK since 1997. This STI is currently treated by a
single injection with penicillin, but resistance to this antibiotic has
developed in other diseases. Imagine the impact if it happened again.
The fever and chills of diphtheria are mainly prevalent in the
developing world, but with travellers contracting typhoid even though a
vaccine is available, the same could happen with diphtheria.
No comments:
Post a Comment